On Friday evening, Prince Andrew announced that he would no longer use the titles or honours granted to him, as the continued ...

Prince William has prepared a list of British Royal Family members who might lost their senior royal titles during his future ...

The notice indicates WhiteOak, a subsidiary of Chinese company Zhejiang Haichang Biotechnology Co Ltd, has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval for a generic ...

Andrew has now voluntarily stopped using his remaining titles but will continue to use his princely status. This is ...

King Charles just stripped his disgraced brother Prince Andrew of his Duke of York title (though technically Andrew announced ...

Arquitos Capital highlights Liquidia’s strong Yutrepia launch, FDA approval, and market potential. See why they believe the ...

Arquitos Capital shares its Q3 2025 investor letter highlighting a 66.8% YTD return and value-driven strategy. Read how ...

Several royals with feel Prince William's wrath when he's king as they won't be keeping their titles or HRH styles.

Boston-based law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has filed a lawsuit against its former client Parus Holdings, Inc., alleging the company failed to pay over $2 million in ...

U.S. Patent and Trademark Office director John Squires announced on Friday that he will determine whether the office's Patent Trial and Appeal Board will hear challenges to the validity of specific ...

US Patent and Trademark Office Director John Squires is taking over the task of deciding whether to grant or reject petitions ...

United Therapeutics Corporation (NASDAQ:UTHR) is one of the best stocks to buy according to Jim Simons’ Renaissance ...